Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
72,719
-
Share change
-
+33,719
-
Total reported value
-
$366,000
-
Price per share
-
$5.79
-
Number of holders
-
5
-
Value change
-
+$221,000
-
Number of buys
-
3
-
Number of sells
-
1
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q1 2017
As of 31 Mar 2017,
Scinai Immunotherapeutics Ltd. - ADSs (BVXV) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,719 shares.
The largest 5 holders included
CITADEL ADVISORS LLC, Vantage Investment Advisors, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Edge Wealth Management LLC, and DEUTSCHE BANK AG\.
This page lists
5
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.